DK0954298T3 - 2,5-dihydroxybenzenesulfonic acid derivatives for the treatment of sexual dysfunction - Google Patents
2,5-dihydroxybenzenesulfonic acid derivatives for the treatment of sexual dysfunctionInfo
- Publication number
- DK0954298T3 DK0954298T3 DK97920619T DK97920619T DK0954298T3 DK 0954298 T3 DK0954298 T3 DK 0954298T3 DK 97920619 T DK97920619 T DK 97920619T DK 97920619 T DK97920619 T DK 97920619T DK 0954298 T3 DK0954298 T3 DK 0954298T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- sexual dysfunction
- acid derivatives
- dihydroxybenzenesulfonic acid
- dihydroxybenzenesulfonic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The use of compounds of formula (I) in drugs for the normalisation of endothelial function, for the treatment of sexual dysfunction, vascular complications of diabetes, and endothelial vascular disorders, is new. R = H or SO3-; B = Ca2+ or H2N+(Et)2; and n, m = 1 or 2.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9604182A FR2747040B1 (en) | 1996-04-03 | 1996-04-03 | 2,5-DIHYDROXYBENZENESULFONIC DERIVATIVES AS MEDICAMENTS FOR NORMALIZING ENDOTHELIAL AND SEXUAL FUNCTION, AND TREATING VASCULAR DISORDERS OF DIABETIC OR ENDOTHELIAL ORIGIN |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0954298T3 true DK0954298T3 (en) | 2006-06-12 |
Family
ID=9490865
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK97920619T DK0954298T3 (en) | 1996-04-03 | 1997-04-03 | 2,5-dihydroxybenzenesulfonic acid derivatives for the treatment of sexual dysfunction |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1637133A3 (en) |
AT (1) | ATE319442T1 (en) |
DK (1) | DK0954298T3 (en) |
ES (1) | ES2127132B1 (en) |
FR (1) | FR2747040B1 (en) |
PT (1) | PT954298E (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3436462A (en) * | 1966-02-01 | 1969-04-01 | Om Lab Sa | Normalizing or reduction of the abnormal permeability of persons having capillar fragility with para-di-hydroxybenzene sulfonate |
FR7465M (en) * | 1968-06-26 | 1969-11-24 | ||
US3681503A (en) * | 1970-04-17 | 1972-08-01 | Om Lab Sa | Method for combating disturbances of the lipid content of the blood |
AR204506A1 (en) | 1972-05-17 | 1976-02-12 | Esteve Labor Dr | PROCEDURE FOR THE PREPARATION OF SALTS OF P-DIHYDROXYBENE DISULPHONIC ACIDS |
-
1996
- 1996-04-03 FR FR9604182A patent/FR2747040B1/en not_active Expired - Fee Related
-
1997
- 1997-04-03 ES ES009700826A patent/ES2127132B1/en not_active Expired - Fee Related
- 1997-04-03 DK DK97920619T patent/DK0954298T3/en active
- 1997-04-03 AT AT97920619T patent/ATE319442T1/en not_active IP Right Cessation
- 1997-04-03 EP EP05112614A patent/EP1637133A3/en not_active Withdrawn
- 1997-04-03 PT PT97920619T patent/PT954298E/en unknown
Also Published As
Publication number | Publication date |
---|---|
ES2127132B1 (en) | 1999-11-16 |
ATE319442T1 (en) | 2006-03-15 |
EP1637133A2 (en) | 2006-03-22 |
ES2127132A1 (en) | 1999-04-01 |
EP1637133A3 (en) | 2007-07-11 |
PT954298E (en) | 2006-07-31 |
FR2747040B1 (en) | 1998-06-26 |
FR2747040A1 (en) | 1997-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LV10575A (en) | Isoxazole-4-carboxylic acid amide and hydroxyalkylidene-cyanoacetic acid amide containing these compounds and their use | |
DK0833839T3 (en) | Heterocyclic peptidyl compounds useful in the treatment of thrombin-related diseases | |
DE122009000012I1 (en) | Substituted pyrazolylbenzenesulfonamides for the treatment of inflammation. | |
DE3872372T2 (en) | COMPOSITION FOR INCREASING INTRA-CELL-ATP LEVELS AND PHYSICAL PERFORMANCE LEVELS AND FOR INCREASING THE SPEED OF Wounds Healing. | |
TR199801180T2 (en) | New compounds with analgesic effect. | |
BR0209468A (en) | Pharmaceutically acceptable compound or salts or solvates thereof, pharmaceutical composition, use of a compound, and method of treating an HPP-mediated disease or condition | |
EA200300717A1 (en) | Heterocyclylindazole and azazin-dazole compounds as 5-hydroxytriptamine-6-ligands | |
DK0825857T3 (en) | Use of gabapentin and its derivatives for the treatment of mania and bipolar disorder | |
FI880387A0 (en) | 1- (4-HYDROXY-3,5-DI-TERT-BUTYLBENZOYL) HOMOPIPERAZINE, DESS OLIKA DERIVAT, FOERFARANDE FOER FRAMSTAELLNING AV DESSA FOERENINGAR, DESSA INNEHAOLLANDE LAEKEMDEL OCH DERAS ANVAENDNING. | |
DK0498144T3 (en) | Use of acetyl L-carnitine in the therapeutic treatment of coma | |
CA2251226A1 (en) | Use of 2,5-dihydroxybenzenesulphonic derivatives in the manufacture of drugs for normalising the endothelial function and treating sexual dysfunctions, the vascular complications of diabetes and vascular disorders of endothelial origin | |
DK0954298T3 (en) | 2,5-dihydroxybenzenesulfonic acid derivatives for the treatment of sexual dysfunction | |
TR199801184T2 (en) | New compounds with analgesic action. | |
DE69419954D1 (en) | Medicines for the treatment of skin diseases | |
NO992985L (en) | Use of COMT inhibitors for the manufacture of a drug to prevent diabetic vascular dysfunction | |
BR0309747A (en) | Method for the Treatment of Endothelial Vascular Growth Factor-Mediated Vascular Disorders | |
HUP9904030A2 (en) | Use of tiagabine for production of pharmaceutical against psychotic disorders | |
ATE53385T1 (en) | SULFINYL AND SULFONYL SUBSTITUTED 3BENZAZEPINES. | |
DK0538690T3 (en) | Arylquinolyl-substituted 1,4-dihydropyridine-dicarboxylic acid derivatives, process for their preparation in drug use | |
ATE212842T1 (en) | QUINOXALINE DERIVATIVES FOR THE TREATMENT OF TINNITUS | |
ATE133647T1 (en) | 3-ARYL AND 3-HETEROARYL-2-FLUORO-1-OLEFINS WITH PHARMACEUTICAL ACTION | |
ATE318591T1 (en) | PHARMACEUTICAL COMPOSITION FOR TREATING OBESITY | |
EA200300789A1 (en) | APPLICATION OF 2-AMINO-1- (4-HYDROXY-3-METHESULPHONE-AMIDOPHENYL) ETHANOL FOR THE TREATMENT OF URINARY HOLDING | |
ATE120956T1 (en) | PYRIMIDO-BENZOTHIAZINE DERIVATIVES FOR THE TREATMENT OF INFLAMMATION, ALLERGY AND CARDIOVASCULAR DISEASE. | |
DE69727827T2 (en) | USE OF 2- (2-MORPHOLINOPHENYL) GUANIDINE DERIVATIVES FOR THE TREATMENT OF DIABETES COMPLICATIONS |